Estradiol diundecylate explained
Estradiol diundecylate (brand name Estrolent), or estradiol diundecanoate, also known as 17β-estradiol 3,17β-diundecylate, is an estrogen and an estrogen ester – specifically, the 3,17β-diundecylate ester of estradiol – which has been marketed in Romania.[1] [2] [3] It was described, along with a variety of other estradiol esters such as estradiol undecylate, by Karl Junkmann of Schering AG in 1953.[4]
See also
Notes and References
- Book: Elks J . The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. 14 November 2014. Springer. 978-1-4757-2085-3. 898.
- Book: Index Nominum 2000: International Drug Directory. January 2000. Taylor & Francis. 978-3-88763-075-1. 406–.
- Book: Muller NF, Dessing RP . European Drug Index: European Drug Registrations, Fourth Edition. 19 June 1998. CRC Press. 978-3-7692-2114-5. 456–.
- Junkmann K . Über protrahiert wirksame Östrogene. Over protracted effective estrogens. Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie. 220. 5. 1953. 0028-1298. 10.1007/BF00246561. 20753905.